A 6 year old boy is still bed wetting sometimes even after peeing and sleeping at night

Reading File
This is nocturnal enuresis - bedwetting in a 6-year-old, which is common and usually benign. Let me search the medical library for detailed guidance.
Searching sources...
Finding Sources
Finding Sources
Searching PubMed

nocturnal enuresis children management

Good results. Now let me read the most relevant sections in parallel.
Reading File
Reading File
Reading File
I have enough information from the textbooks. Let me also quickly check the Harriet Lane desmopressin dosing section for pediatric specifics.
Reading File
I now have comprehensive information to give a thorough, well-sourced answer.

Nocturnal Enuresis (Bedwetting) in a 6-Year-Old Boy

Is This Normal?

Yes - at age 6, bedwetting is still within the normal range. A child must be at least 5 years old before the term "enuresis" even applies clinically. Most children achieve nighttime dryness by age 5-7, and many 6-year-olds still have occasional accidents. It is more common in boys and has a strong genetic tendency (if a parent wet the bed, the child has a ~44% chance of doing so too).
  • Harrison's Principles of Internal Medicine, 22E notes: "Before age 5 or 6 years, nocturnal enuresis should be considered a normal variant."

Primary vs. Secondary Enuresis

The first important distinction is:
TypeDefinitionSignificance
PrimaryChild has never been consistently dry at nightMost common; usually maturational
SecondaryReturns after 6+ months of drynessMay signal stress, UTI, diabetes, or another pathologic cause
Based on your description, this sounds like primary nocturnal enuresis - he simply hasn't fully outgrown nighttime wetting yet. Secondary enuresis warrants more investigation.

What Causes It?

The exact cause is unknown, but contributing factors include:
  • Developmental delay in arousal from sleep (the child sleeps deeply and doesn't wake to a full bladder signal)
  • Nocturnal polyuria - the kidneys produce too much urine at night due to insufficient antidiuretic hormone (ADH/vasopressin) release during sleep
  • Small functional bladder capacity
  • Genetics - strong family history association
  • Psychological factors, life stressors, and family dynamics have not been shown to have a causal relationship

When to See a Doctor

See a paediatrician if any of these are present:
  • Child was dry for 6+ months and has relapsed (secondary enuresis)
  • Daytime wetting as well (diurnal enuresis)
  • Pain, burning, or discomfort when urinating
  • Unusual thirst or drinking a lot (could suggest diabetes)
  • Straining to urinate, weak stream, or dribbling
  • Wetting that is very frequent (multiple times per night)
  • Any signs of constipation (can worsen enuresis)
  • Any neurological symptoms (back pain, abnormal gait)
A basic work-up includes urinalysis and a simple physical examination. If those are normal, no further testing is usually needed.

What You Can Do at Home (First-Line)

These behavioural measures are tried first and are effective for many children:
  1. Fluid management - offer most fluids earlier in the day; reduce intake in the 1-2 hours before bed. Avoid caffeinated, sugary, or fizzy drinks in the evening.
  2. Regular voiding schedule - encourage the child to pee right before bed (even if he just went a little earlier - have him try again).
  3. Reward/star chart - give positive reinforcement for dry nights without shame or punishment for wet ones.
  4. Protect the mattress - a waterproof mattress cover and easy-change bedding reduces stress for the whole family.
  5. Maintain regular bowel habits - constipation compresses the bladder and worsens enuresis.
  6. "Lifting" - gently waking the child 1.5-2 hours after he falls asleep to take him to the toilet can reduce the number of wet nights.
  7. Reassurance - the child should not feel shame. Most children will be dry by age 7; reassurance alone is appropriate at this age.

If Home Measures Don't Work

Bedwetting Alarm (Most Effective Treatment)

A moisture-sensing alarm wakes the child the moment wetting begins, training the brain over weeks to respond to bladder signals. This is considered the most effective long-term treatment for nocturnal enuresis. It requires commitment (6-16 weeks) and parental involvement.
  • Textbook of Family Medicine 9e: "A bedwetting alarm is the most effective treatment for nocturnal enuresis."

Medications (if alarm fails or isn't feasible)

DrugMechanismNotes
Desmopressin (DDAVP)Synthetic ADH - reduces urine production at nightBest for nocturnal polyuria; oral dose starts at 0.2 mg at bedtime; effective but high relapse when stopped
Antimuscarinics (e.g. oxybutynin)Relaxes the bladderUsed when small/overactive bladder is the issue
Tricyclics (e.g. imipramine)Multiple mechanismsEffective but side effects (cardiac arrhythmias, drowsiness) limit use; rarely first-line
Medications are effective but not curative - relapse rates are high once stopped. They are usually reserved for situations where the child's quality of life is affected (e.g., unable to attend sleepovers, summer camps).

Bottom Line for This Child

At 6 years old with occasional bedwetting, this is very likely normal primary nocturnal enuresis. No urgent workup is needed if he is otherwise healthy, has no daytime symptoms, and was never consistently dry. The most practical steps right now:
  1. Reassure him (and yourselves) - no blame or shame
  2. Cut back fluids 1-2 hours before bed and ensure he voids right before sleeping
  3. Use a waterproof mattress cover
  4. Consider a reward chart for dry nights
  5. If he's still wetting regularly past age 7, or if it's causing him distress, speak to your paediatrician about a bedwetting alarm
Recent systematic review evidence (2025) confirms these behavioural approaches remain first-line, with pharmacotherapy as second-line when needed.
Note: This information is general guidance. If you notice any daytime wetting, pain on urination, unusual thirst, or if bedwetting returns after a dry period, please consult a doctor.

How to report zn and gram staining of csf in a clinical pathology lab

Reading File
This is a clinical pathology / microbiology lab reporting question - broad topic covering CSF staining procedures and reporting formats. Let me search in parallel.
Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Good, now let me read the most relevant detailed sections in parallel - Henry's Clinical Lab Methods (the gold standard for lab reporting), the CSF Gram stain section, and the ZN/AFB sections.
Reading File
Reading File
Reading File
Now let me get the Henry's Lab Methods section for detailed CSF staining reporting specifics, and search for lab reporting format for AFB.
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching Images

gram stain CSF cerebrospinal fluid bacteria microscopy

This figure demonstrates cerebrospinal fluid (CSF) bulk flow within the perivascular space (PVS) using in vivo two-photon microscopy in a mouse model. Panel A illustrates the experimental setup with a schematic of a cranial window and cranial microscopy objective. Sequential time-lapse fluorescence images, captured at 30 Hz, show branching cerebral vasculature (labeled in red) and intravenously (I.V.) administered green dextran microspheres. High-magnification insets with purple arrows indicate particle velocity and directionality, demonstrating flow relative to the vessel walls (marked by white dashed lines). Panel B provides a particle tracking velocimetry summary, where multi-colored particle tracks are superimposed on a grayscale anatomical image of the perivascular spaces. The dense, interwoven trajectories visualize the complex, unidirectional transport of solutes through the glymphatic system. This image is used in neurobiology to illustrate the physiological mechanisms of brain waste clearance and CSF-interstitial fluid (ISF) exchange.

This figure demonstrates cerebrospinal fluid (CSF) bulk flow within the perivascular space (PVS) using in vivo two-photon microscopy in a mouse model. Panel A illustrates the experimental setup with a schematic of a cranial window and cranial microscopy objective. Sequential time-lapse fluorescence images, captured at 30 Hz, show branching cerebral vasculature (labeled in red) and intravenously (I.V.) administered green dextran microspheres. High-magnification insets with purple arrows indicate particle velocity and directionality, demonstrating flow relative to the vessel walls (marked by white dashed lines). Panel B provides a particle tracking velocimetry summary, where multi-colored particle tracks are superimposed on a grayscale anatomical image of the perivascular spaces. The dense, interwoven trajectories visualize the complex, unidirectional transport of solutes through the glymphatic system. This image is used in neurobiology to illustrate the physiological mechanisms of brain waste clearance and CSF-interstitial fluid (ISF) exchange.

This composite diagnostic image presents two light microscopy views of pleural fluid highlighting the microbiological identification of Nocardia species. Panel (a) shows a Gram stain at high magnification, demonstrating Gram-positive (purple-stained), thin, beaded, and branching filamentous bacteria. Panel (b) illustrates a modified Ziehl-Neelsen (ZN) stain of the same clinical specimen. The bacteria exhibit weak acid-fast properties, characterized by pink-to-red filamentous structures that retain the primary stain against a light blue counterstained background. Arrows in both panels indicate the characteristic filamentous and branching morphology. This combination of Gram-positive branching filaments and partial acid-fastness is a key diagnostic feature used to distinguish Nocardia from other filamentous bacteria like Actinomyces. These findings are clinically significant in diagnosing thoracic nocardiosis in immunocompromised patients or those with pre-existing pulmonary disease.

This composite diagnostic image presents two light microscopy views of pleural fluid highlighting the microbiological identification of Nocardia species. Panel (a) shows a Gram stain at high magnification, demonstrating Gram-positive (purple-stained), thin, beaded, and branching filamentous bacteria. Panel (b) illustrates a modified Ziehl-Neelsen (ZN) stain of the same clinical specimen. The bacteria exhibit weak acid-fast properties, characterized by pink-to-red filamentous structures that retain the primary stain against a light blue counterstained background. Arrows in both panels indicate the characteristic filamentous and branching morphology. This combination of Gram-positive branching filaments and partial acid-fastness is a key diagnostic feature used to distinguish Nocardia from other filamentous bacteria like Actinomyces. These findings are clinically significant in diagnosing thoracic nocardiosis in immunocompromised patients or those with pre-existing pulmonary disease.

The image consists of two panels showcasing cerebrospinal fluid (CSF) analysis techniques. On the left, a macro photograph displays a 10 mm diameter polycarbonate filter with 0.6 um pores mounted in an airtight device. A red circular annotation in the center highlights the concentrated area of morphological structures obtained via vacuum suction of 200 uL of CSF. On the right, a scanning electron microscopy (SEM) image at 2000x magnification reveals the ultrastructural morphology of a healthy control sample. The SEM view shows a cluster of spherical particles, measuring approximately 0.1–0.2 um in diameter, situated on the porous filter surface. In the upper left quadrant, a phagocytic-type cell is visible, featuring a thin chord-like extension or pseudopod reaching towards the central aggregate of spherical particles. The image illustrates the use of filtration and electron microscopy in clinical research to identify potential biomarkers or atypical morphological structures within the CSF.

The image consists of two panels showcasing cerebrospinal fluid (CSF) analysis techniques. On the left, a macro photograph displays a 10 mm diameter polycarbonate filter with 0.6 um pores mounted in an airtight device. A red circular annotation in the center highlights the concentrated area of morphological structures obtained via vacuum suction of 200 uL of CSF. On the right, a scanning electron microscopy (SEM) image at 2000x magnification reveals the ultrastructural morphology of a healthy control sample. The SEM view shows a cluster of spherical particles, measuring approximately 0.1–0.2 um in diameter, situated on the porous filter surface. In the upper left quadrant, a phagocytic-type cell is visible, featuring a thin chord-like extension or pseudopod reaching towards the central aggregate of spherical particles. The image illustrates the use of filtration and electron microscopy in clinical research to identify potential biomarkers or atypical morphological structures within the CSF.

The second image showing Gram + ZN stain of a clinical specimen is directly relevant. Let me fetch the CSF Gram stain image from Henry's and compile the complete answer now.
Loading Image
Loading Image
I now have comprehensive material to write a thorough, practical answer on how to report ZN and Gram staining of CSF in a clinical pathology lab.

Reporting ZN and Gram Staining of CSF in a Clinical Pathology Lab


Pre-Analytical Step: CSF Concentration (Critical)

CSF is a low-cellularity, low-organism-burden specimen. Unlike sputum or pus, organisms in CSF are often below the direct microscopy detection threshold (~10⁵ CFU/mL). Therefore:
Always concentrate CSF by centrifugation before making smears.
  • Centrifuge at 1500-2000 rpm for 10-15 minutes
  • Discard most of the supernatant (keep a small amount to resuspend the pellet)
  • Use the resuspended pellet for smear preparation
  • Prepare at least 2 smears from the deposit - one for Gram stain, one for ZN/AFB stain
  • Allow smears to air-dry, then heat-fix gently
The volume of CSF submitted matters enormously - more CSF = higher sensitivity. A minimum of 3-5 mL is recommended; larger volumes (up to 10 mL) increase AFB yield in suspected tuberculous meningitis.

GRAM STAIN OF CSF

Purpose

Rapid diagnosis of bacterial meningitis - identifies bacterial morphology and Gram reaction within 30-60 minutes.

Sensitivity (know this before reporting)

OrganismGram Stain Sensitivity
Streptococcus pneumoniae~90%
Neisseria meningitidis~75-85%
Gram-negative bacilli (E. coli, Klebsiella)50-80%
Listeria monocytogenes≤50%
Overall bacterial meningitis60-90%
Sensitivity drops to ~30% lower in partially treated meningitis cases.

Reading the Gram Stain - What to Look For

Examine under oil immersion (100x) after scanning at 40x. Examine at least 20-30 fields systematically.
FindingAppearanceLikely Organism
Gram-positive diplococci (lancet-shaped)Purple, paired cocciS. pneumoniae
Gram-negative diplococci (intracellular)Pink, paired cocci inside PMNsN. meningitidis
Gram-positive cocci in clustersPurple clustersStaphylococcus spp.
Gram-negative coccobacilli or bacilliPink rodsE. coli, H. influenzae, Klebsiella
Gram-positive short rodsPurple rods (often intracellular in monocytes)Listeria monocytogenes
Gram-positive rods (large, boxcar-shaped)Purple, squared-off rodsBacillus anthracis (rare)
Also note the WBC background - PMN predominance suggests bacterial; lymphocytic predominance suggests viral/TB/fungal.

How to Write the Gram Stain Report

Negative result:
Gram Stain of CSF (concentrated deposit):
- No organisms seen on Gram stain
- WBCs: [present / absent / numerous]
- Background: [clear / slightly turbid deposit]
- Culture and sensitivity awaited
Positive result (example - pneumococcal meningitis):
Gram Stain of CSF (concentrated deposit):
- Gram-positive diplococci (lancet-shaped) seen - intracellular and extracellular
- Numerous polymorphonuclear leukocytes present
- Morphology consistent with Streptococcus pneumoniae
- Urgent: Result telephoned to clinician at [time]
- Culture and sensitivity in progress
Reporting conventions:
DescriptorMeaning
Rare / occasional1-5 organisms per 100 fields
Few1-5 per 10 fields
Moderate5-10 per field
Many / numerous>10 per field
  • Always describe organism morphology (cocci/bacilli/diplococci), Gram reaction (positive/negative), and arrangement (pairs, clusters, chains)
  • Note if organisms are intracellular (inside PMNs) - strongly supports pathogenicity
  • Note the background cellularity (WBCs: PMNs vs lymphocytes)
  • Any positive result must be phoned to the clinician immediately - this is a critical/panic value

ZN (ZIEHL-NEELSEN) STAIN OF CSF

Purpose

Detection of acid-fast bacilli (AFB) in suspected tuberculous meningitis (TBM). Also may detect Nocardia (weakly acid-fast) if done with modified ZN.

Sensitivity - Important Limitation

ZN stain on CSF has low sensitivity (10-40%) even in culture-confirmed TBM. This is because:
  • The AFB load in CSF is typically very low
  • The organism is difficult to concentrate even with centrifugation
  • Results depend on the volume of CSF submitted and persistence of searching
Per Adams & Victor's Principles of Neurology: "Success with the traditional identification of tubercle bacilli in smears of CSF sediment stained by the Ziehl-Neelsen method is a function not only of their number but also of the persistence with which they are sought."
Yield can be increased by:
  • Examining large volumes (≥5 mL, ideally 10 mL) of CSF
  • Multiple serial LPs (repeated 2-3 times)
  • Examining the fibrin web/pellicle that forms in TBM CSF if the specimen is allowed to stand

Reading the ZN Stain

  • Scan at 10x first, then confirm at 40x, and identify at 100x (oil)
  • AFB appear as bright red/pink slender rods against a blue counterstain background
  • They are often beaded and may be curved
  • Search at least 300 fields in a concentrated CSF smear before calling negative (IUATLD recommendation)
  • For CSF (a paucibacillary sample), a minimum of 100-200 fields should be examined
Gram stain (a) and modified ZN stain (b) of clinical specimen showing Gram-positive branching filaments (Nocardia). Note the characteristic pink/red AFB staining against blue background in panel (b).

WHO/IUATLD Grading Scale for AFB Smear Reporting

This standardized scale applies to all AFB smears (sputum is the reference, but the same grading is used for CSF):
GradeNumber of AFB seenReport as
Not seen0 AFB in 100 fields (min)No AFB seen
Scanty1-9 AFB per 100 fieldsScanty - specify exact number (e.g., "Scanty: 3 AFB seen in 100 fields")
1+10-99 AFB per 100 fields1+
2+1-10 AFB per field (in 50 fields)2+
3+>10 AFB per field (in 20 fields)3+
Note for CSF: Given the very low bacillary load, most positive CSF ZN results will be graded "Scanty" - do not discard a scanty result. Report it with the exact count and it is clinically significant.

How to Write the ZN Stain Report

Negative result:
Ziehl-Neelsen Stain for AFB of CSF (concentrated deposit):
- No acid-fast bacilli seen in [number] fields examined
- Minimum 100 fields examined at oil immersion
- Note: Sensitivity of ZN stain on CSF is low (10-40%).
  A negative result does not exclude tuberculous meningitis.
  Culture for AFB and nucleic acid amplification testing (NAAT/PCR) recommended.
Positive result:
Ziehl-Neelsen Stain for AFB of CSF (concentrated deposit):
- Acid-fast bacilli seen: SCANTY (3 AFB in 100 fields)
  [or 1+ / 2+ / 3+ as applicable]
- Morphology: Slender, beaded, pink-red rods consistent with Mycobacterium spp.
- URGENT: Result telephoned to clinician at [time]
- AFB culture and sensitivity in progress
- Molecular test (GeneXpert MTB/RIF / PCR) recommended for confirmation

Key Points for the Lab Report - Summary

FeatureGram StainZN Stain
Specimen prepCentrifuge, use depositCentrifuge, use deposit
Stain usedCrystal violet, Gram's iodine, decolourise, safraninCarbol fuchsin (heat or cold), acid-alcohol decolourise, methylene blue
Reading magnification100x oil immersion100x oil immersion
Minimum fields to scan20-30 per smear100-200 per smear (CSF)
Positive appearanceGram+ = purple; Gram- = pinkAFB = bright red on blue background
Grading systemRare/Few/Moderate/Many + morphology + arrangementWHO/IUATLD 0/Scanty/1+/2+/3+
Sensitivity in CSF60-90% (bacterial meningitis)10-40% (TBM)
Panic value actionPhone clinician immediatelyPhone clinician immediately
Add-on commentRecommend culture and sensitivityRecommend AFB culture + GeneXpert/PCR

General Reporting Reminders

  1. Always state specimen type and preparation method (concentrated deposit)
  2. Note the quality of the smear (adequate cellularity, thin smear, well-stained)
  3. A negative stain never excludes infection - always recommend culture
  4. CSF results are critical values - positive findings must be communicated verbally to the clinician and documented with time/person notified
  5. If you see organisms that don't fit a clear category (e.g., branching filaments), consider modified ZN for Nocardia (partially acid-fast = decolourise with 1% H₂SO₄ instead of acid-alcohol)
Sources: Henry's Clinical Diagnosis and Management by Laboratory Methods; Medical Microbiology 9e; Adams & Victor's Principles of Neurology 12e; WHO/IUATLD AFB grading standards.
This is a shared conversation. Sign in to Orris to start your own chat.